Literature DB >> 25982599

Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans.

A Sharifzadeh1, A R Khosravi2, H Shokri3, G Sharafi1.   

Abstract

OBJECTIVE: Trachyspermum ammi (T. ammi) has been known as having many therapeutic properties and its antimicrobial activity has currently received a renewed interest. This study aimed to verify the effectiveness of T. ammi essential oil to inhibit the growth of Candida albicans (C. albicans) strains isolated from HIV(+) patients with oropharyngeal candidiasis (OPC).
MATERIALS AND METHODS: The essential oil was obtained by hydrodistillation in a Clevenger apparatus and analyzed by gas chromatography. Susceptibility tests were expressed as inhibition zone by the disk diffusion method and minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) by the broth microdilution method.
RESULTS: Thymol (63.4%), p-cymene (19%) and γ-terpinen (16.9%) were found as the most abundant constituents. The disk diffusion results revealed that 67% of oral C. albicans isolates were susceptible, 9% susceptible-dose dependent and 24% resistant to fluconazole. In the broth microdilution method, 68% of isolates were susceptible, 5% susceptible-dose dependent and 27% resistant to fluconazole. The increase in concentration led to a significant reduction in yeasts that were growing in exponential phase. In addition, with increasing in T. ammi oil concentration, the time of remaining cells in lag phase was significantly increased.
CONCLUSION: This study showed that all clinical C. albicans isolates were susceptible to T. ammi essential oil, indicating a significant reduction in the yeast growth in exponential phase.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Candida; Candidose oro-pharyngée; Fluconazole; HIV patients; OPC; Thymol; Trachyspermum ammi; VIH

Mesh:

Substances:

Year:  2015        PMID: 25982599     DOI: 10.1016/j.mycmed.2015.03.008

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  6 in total

Review 1.  Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi.

Authors:  Hafsa Qadri; Abdul Haseeb Shah; Syed Mudasir Ahmad; Bader Alshehri; Abdullah Almilaibary; Manzoor Ahmad Mir
Journal:  Saudi J Biol Sci       Date:  2022-07-18       Impact factor: 4.052

2.  Antibacterial and Antifungal Activities of Ethiopian Medicinal Plants: A Systematic Review.

Authors:  Dereje Nigussie; Gail Davey; Takele Beyene Tufa; Malcolm Brewster; Belete Adefris Legesse; Abebaw Fekadu; Eyasu Makonnen
Journal:  Front Pharmacol       Date:  2021-06-01       Impact factor: 5.988

Review 3.  Oropharyngeal Candidosis in HIV-Infected Patients-An Update.

Authors:  Shankargouda Patil; Barnali Majumdar; Sachin C Sarode; Gargi S Sarode; Kamran H Awan
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

Review 4.  Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents.

Authors:  Giselle C de Oliveira Santos; Cleydlenne C Vasconcelos; Alberto J O Lopes; Maria do S de Sousa Cartágenes; Allan K D B Filho; Flávia R F do Nascimento; Ricardo M Ramos; Emygdia R R B Pires; Marcelo S de Andrade; Flaviane M G Rocha; Cristina de Andrade Monteiro
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640

5.  Oral colonization by Candida species and associated factors in HIV-infected patients in Ahvaz, southwest Iran.

Authors:  Elham Aboualigalehdari; Maryam Tahmasebi Birgani; Mahnaz Fatahinia; Mehran Hosseinzadeh
Journal:  Epidemiol Health       Date:  2020-05-24

6.  In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST.

Authors:  Mahnaz Fatahinia; Marzieh Halvaeizadeh; Ali Zarei Mahmoudabadi; Elham AboualiGalehdari; Neda Kiasat
Journal:  Curr Med Mycol       Date:  2020-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.